908 Devices (MASS) Revenue Growth (3y) (2023 - 2026)
908 Devices (MASS) Revenue Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.43 Bn | 193.83 Bn | 7.27 Bn | 8.07% |
| 2 | Stryker | 126.52 Bn | 123.04 Bn | 4.50 Bn | 9.66% |
| 3 | Medtronic | 118.76 Bn | 109.54 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 14.78% |
| 5 | Edwards Lifesciences | 52.20 Bn | 47.95 Bn | 1.35 Bn | 10.83% |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 14.51% |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.65 Bn | 2.18 Bn | 3.20% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 25.44% |
| 9 | Steris | 23.09 Bn | 22.61 Bn | 684.20 Mn | 8.05% |
| 10 | 908 Devices | 385.58 Mn | 284.05 Mn | 8.34 Mn | 9.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.95% |
| Mar 31, 2026 | 12.15% |
| Dec 31, 2025 | 14.29% |
| Sep 30, 2025 | -3.93% |
| Jun 30, 2025 | 5.48% |
| Mar 31, 2025 | 12.34% |
| Dec 31, 2024 | -3.26% |
| Sep 30, 2024 | 4.99% |
| Jun 30, 2024 | 11.46% |
| Mar 31, 2024 | 10.22% |
| Dec 31, 2023 | 35.91% |
| Sep 30, 2023 | 33.21% |
| Jun 30, 2023 | 2.81% |
| Mar 31, 2023 | 33.35% |